
MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy's Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aKMoUG
via
IFTTT
0 comments:
Post a Comment